T-R (Test-Reference drug)

DRUG3 trials

Sponsors

Dong-A Pharmaceutical Co., Ltd., Suzhou Centergene Pharmaceuticals Co.,Ltd., Simcere Pharmaceutical Co., Ltd

Conditions

Assisted Reproductive TechnologyFemale InfertilityHealthy ParticipantsInduction of OvulationInfertility

Phase 1

A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

CompletedNCT01851512

Dong-A Pharmaceutical Co., Ltd.Induction of Ovulation, Infertility

Start: 2010-05-31End: 2011-04-30Updated: 2013-05-16

A Comparing Study Between SJ04 and Ovidrel® in Healthy Subjects

RecruitingNCT06599528

Suzhou Centergene Pharmaceuticals Co.,Ltd.Assisted Reproductive Technology, Female Infertility

Start: 2024-08-12End: 2026-12-31Target: 48Updated: 2025-02-10

A Crossover Study to Evaluate the Relative Bioavailability of Two Formulations of Deuterated Remdesivir Hydrobromide for Oral Suspension in Healthy Chinese Adults

Not yet recruitingNCT07510529

Simcere Pharmaceutical Co., LtdHealthy Participants

Start: 2026-04-20End: 2026-06-30Target: 48Updated: 2026-04-03